Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Rybak

Showing results (481-490 of 531) with videos related to

Pageof 54
Sort By:
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|March 20, 2020
Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases PharmacistsMichael J Rybak, Jennifer Le, Thomas P Lodise, et al.
Pharmacotherapy|April 1, 2020
Executive Summary: Therapeutic Monitoring of Vancomycin for Serious Methicillin-Resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases PharmacistsMichael J Rybak, Jennifer Le, Thomas P Lodise, et al.
The Journal of Antimicrobial Chemotherapy|May 6, 2017
Evaluation of daptomycin combinations with cephalosporins or gentamicin against Streptococcus mitis group strains in an in vitro model of simulated endocardial vegetations (SEVs)Juwon Yim, Jordan R Smith, Nivedita B Singh, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 7, 2011
Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and childrenCatherine Liu, Arnold Bayer, Sara E Cosgrove, et al.
Antimicrobial Agents and Chemotherapy|December 5, 2018
Mutations in <i>cdsA</i> and <i>pgsA</i> Correlate with Daptomycin Resistance in <i>Streptococcus mitis</i> and <i>S. oralis</i>Truc T Tran, Nagendra N Mishra, Ravin Seepersaud, et al.
Infectious Diseases and Therapy|February 24, 2020
Evaluation of the INCREMENT-CPE, Pitt Bacteremia and qPitt Scores in Patients with Carbapenem-Resistant Enterobacteriaceae Infections Treated with Ceftazidime-AvibactamSarah C J Jorgensen, Trang D Trinh, Evan J Zasowski, et al.
American Journal of Infection Control|September 10, 2013
Risk factors for and epidemiology of community-onset vancomycin-resistant Enterococcus faecalis in southeast MichiganAdedayo Morenike Omotola, Yumeng Li, Emily T Martin, et al.
Open Forum Infectious Diseases|March 13, 2020
Real-world Multicenter Analysis of Clinical Outcomes and Safety of Meropenem-Vaborbactam in Patients Treated for Serious Gram-Negative Bacterial InfectionsSara Alosaimy, Sarah C J Jorgensen, Abdalhamid M Lagnf, et al.
Open Forum Infectious Diseases|February 25, 2021
Preliminary, Real-world, Multicenter Experience With Omadacycline for <i>Mycobacterium abscessus</i> InfectionsTaylor Morrisette, Sara Alosaimy, Julie V Philley, et al.
The Annals of Pharmacotherapy|December 6, 2012
Treatment of methicillin-resistant Staphylococcus aureus infections with a minimal inhibitory concentration of 2 μg/mL to vancomycin: old (trimethoprim/sulfamethoxazole) versus new (daptomycin or linezolid) agentsMichelle L Campbell, Dror Marchaim, Jason M Pogue, et al.
Pageof 54

Showing results (481-490 of 531) with videos related to

Sort By:
Pageof 54
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|March 20, 2020
Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases PharmacistsMichael J Rybak, Jennifer Le, Thomas P Lodise, et al.
Pharmacotherapy|April 1, 2020
Executive Summary: Therapeutic Monitoring of Vancomycin for Serious Methicillin-Resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases PharmacistsMichael J Rybak, Jennifer Le, Thomas P Lodise, et al.
The Journal of Antimicrobial Chemotherapy|May 6, 2017
Evaluation of daptomycin combinations with cephalosporins or gentamicin against Streptococcus mitis group strains in an in vitro model of simulated endocardial vegetations (SEVs)Juwon Yim, Jordan R Smith, Nivedita B Singh, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 7, 2011
Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and childrenCatherine Liu, Arnold Bayer, Sara E Cosgrove, et al.
Antimicrobial Agents and Chemotherapy|December 5, 2018
Mutations in <i>cdsA</i> and <i>pgsA</i> Correlate with Daptomycin Resistance in <i>Streptococcus mitis</i> and <i>S. oralis</i>Truc T Tran, Nagendra N Mishra, Ravin Seepersaud, et al.
Infectious Diseases and Therapy|February 24, 2020
Evaluation of the INCREMENT-CPE, Pitt Bacteremia and qPitt Scores in Patients with Carbapenem-Resistant Enterobacteriaceae Infections Treated with Ceftazidime-AvibactamSarah C J Jorgensen, Trang D Trinh, Evan J Zasowski, et al.
American Journal of Infection Control|September 10, 2013
Risk factors for and epidemiology of community-onset vancomycin-resistant Enterococcus faecalis in southeast MichiganAdedayo Morenike Omotola, Yumeng Li, Emily T Martin, et al.
Open Forum Infectious Diseases|March 13, 2020
Real-world Multicenter Analysis of Clinical Outcomes and Safety of Meropenem-Vaborbactam in Patients Treated for Serious Gram-Negative Bacterial InfectionsSara Alosaimy, Sarah C J Jorgensen, Abdalhamid M Lagnf, et al.
Open Forum Infectious Diseases|February 25, 2021
Preliminary, Real-world, Multicenter Experience With Omadacycline for <i>Mycobacterium abscessus</i> InfectionsTaylor Morrisette, Sara Alosaimy, Julie V Philley, et al.
The Annals of Pharmacotherapy|December 6, 2012
Treatment of methicillin-resistant Staphylococcus aureus infections with a minimal inhibitory concentration of 2 μg/mL to vancomycin: old (trimethoprim/sulfamethoxazole) versus new (daptomycin or linezolid) agentsMichelle L Campbell, Dror Marchaim, Jason M Pogue, et al.
Pageof 54